Inside information: Nexstim Plc Agrees on Next Phase of Exclusivity Agreement with Sinaptica Therapeutics, Inc. Nexstim Plc ("Nexstim" or ...

Vidya Valley School, Kharar, celebrates the achievements of its students at the National and International Abacus Competition ...

Please note that some of the information you will hear during our discussion today will consist of forward-looking statements, including, without limitation, those regarding revenue and future ...

Sanofi and Regeneron’s Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma Approval based on global phase 3 program in children demonstrating Dupixent significantly ...

This study provides important evidence that negative affect is associated with slower cognitive processing in daily life, with findings replicated across three independent samples and supported by ...

Olaplex's technical rebound and future growth potential. Learn here to know why OLPX shares could be undervalued in the beauty sector.